Blue Bell Private Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Blue Bell Private Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-268	Closed	-$2K	–	831
2022 Q2	$2K	Hold	268	–	–	﹤0.01%	656
2022 Q1	$3K	Hold	268	–	–	﹤0.01%	649
2021 Q4	$2K	Buy	+268	New	+$2.42K	﹤0.01%	711
2016 Q4	–	Sell	-504	Closed	-$24K	–	381
2016 Q3	$24K	Hold	504	–	–	0.01%	275
2016 Q2	$26K	Hold	504	–	–	0.02%	262
2016 Q1	$27K	Hold	504	–	–	0.02%	268
2015 Q4	$33K	Hold	504	–	–	0.02%	256
2015 Q3	$28K	Hold	504	–	–	0.02%	279
2015 Q2	$30K	Hold	504	–	–	0.02%	274
2015 Q1	$31K	Sell	504 -64	-11%	-$3.72K	0.02%	265
2014 Q4	$32K	Hold	568	–	–	0.02%	273
2014 Q3	$31K	Hold	568	–	–	0.02%	294
2014 Q2	$30K	Hold	568	–	–	0.02%	279
2014 Q1	$30K	Buy	568 +64	+13%	+$2.96K	0.02%	248
2013 Q4	$20K	Buy	+504	New	+$19.8K	0.02%	320

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Blue Bell Private Wealth Management's TEVA Position: Q3 2022 in Review

Blue Bell Private Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2022, closing a stake of 268 shares — an estimated $2K sold.

Blue Bell Private Wealth Management first reported a position in TEVA in Q4 2013 and held it in 15 quarters. The position peaked at $33K in Q4 2015. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

Blue Bell Private Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2022 after selling out during the quarter.
Blue Bell Private Wealth Management sold 268 Teva Pharmaceutical Industries Limited shares in Q3 2022, an estimated $2K.
Blue Bell Private Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 15 quarters.
Blue Bell Private Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $33K in Q4 2015.
430 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2022.

Based on Blue Bell Private Wealth Management's 13F filing for Q3 2022, filed 9 Nov 2022.